19 May 2026
Regulatory and reimbursement pathways for MedTech innovators
in partnership with MedTech Strategist
Discussants:
M. W. Kayo, J. DITTMER
Summary
This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the US and Europe, offering strategic guidance for startups and scale-ups to navigate these complex landscapes effectively.